A successful vasectomy reversal is the first step to fatherhood after vasectomy. Over thirteen million men in the United States are diagnosed with hypogonadism (low testosterone) annually. The Hypogonadism in Men trial revealed that 39% of men are hypogonadal by the age of 45 and it is not uncommon to see men in much younger ages with hypogonadism these days. This makes for a fair amount of cross over for men who are desiring a vasectomy reversal to reinstitute fertility potential and men who are hypogonadal. It is critical for men who are planning on, or who have undergone vasectomy reversal to not be on traditional testosterone replacements such as gels, injections, patches, or pellets; as they suppress sperm production. A better option for the treatment of hypogonadism in a manner that is not detrimental to a man’s fertility is with a medication called clomiphene citrate, which increases testosterone production in a testicular stimulating manner. As an expert in the field, Dr. Kavoussi has co-authored a scientific review article on the use of clomiphene citrates for hypogonadal men.
To read the article click here… https://www.sciencedirect.com/science/article/pii/S2050052118301094?via%3Dihub